<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 8.4: Cardiovascular Disease and the Diabetes Link</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - RED/BURGUNDY theme for Cardiovascular/Diabetes */
        .module-header {
            background: linear-gradient(135deg, #991b1b 0%, #dc2626 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #991b1b;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #991b1b;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #991b1b;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        @media (max-width: 600px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }

        /* Learning Objectives */
        .objectives-box {
            background: #fef2f2;
            border: 2px solid #ef4444;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #991b1b;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #991b1b;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #ef4444;
        }

        .term-item .term {
            font-weight: 700;
            color: #991b1b;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #991b1b;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #fee2e2 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #991b1b 0%, #dc2626 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #991b1b 0%, #dc2626 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        .data-table th {
            background: #f9fafb;
            padding: 15px 20px;
            font-weight: 600;
            color: #991b1b;
            border-bottom: 2px solid #e5e7eb;
        }

        .data-table td {
            padding: 15px 20px;
            border-bottom: 1px solid #f3f4f6;
            color: #4b5563;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #991b1b;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #991b1b;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #fef2f2;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways */
        .takeaways-box {
            background: linear-gradient(135deg, #f5f5f5 0%, #e8e8e8 100%);
            padding: 22px 25px;
            margin-top: 35px;
            border-radius: 8px;
            border: 1px solid #ddd;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #f9fafb;
            border-radius: 12px;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-top: 0;
        }

        .references-box ul {
            padding-left: 20px;
            margin-bottom: 0;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
            opacity: 0.9;
        }

        .lesson-footer .brand {
            color: #991b1b;
            font-weight: 600;
            margin: 0;
            font-size: 15px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 8: Advanced Pathophysiology & Complications</p>
            <h1 class="lesson-title">Lesson 8.4: Cardiovascular Disease and the Diabetes Link</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 4 of 6</span>
            </div>
        </header>

        <!-- Table of Contents -->
        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The "Diabetic Heart" Paradox</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Endothelial Dysfunction Mechanisms</a></li>
                <li><a href="#section3"><span class="section-num">3</span>The Atherogenic Triad</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Glycemic Variability & Oxidative Stress</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Advanced Biomarkers</a></li>
                <li><a href="#section6"><span class="section-num">6</span>STABLE Methodâ„¢ Cardioprotection</a></li>
            </ul>
        </div>

        <!-- Learning Objectives -->
        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the pathophysiological pathways linking chronic hyperglycemia to macrovascular damage.</li>
                <li>Differentiate between standard dyslipidemia and the "Atherogenic Triad" found in diabetic patients.</li>
                <li>Evaluate the impact of <span class="highlight">glycemic variability (GV)</span> on endothelial nitric oxide production.</li>
                <li>Identify advanced cardiovascular markers beyond the standard lipid panel for diabetic risk assessment.</li>
                <li>Apply the STABLE Methodâ„¢ principles to reduce cardiovascular risk via non-pharmacological interventions.</li>
            </ul>
        </div>

        <h2 id="section1">The "Diabetic Heart" Paradox</h2>

        <p>Cardiovascular disease (CVD) is the leading cause of morbidity and mortality for individuals with diabetes. A 2021 meta-analysis involving over 4.5 million participants found that adults with Type 2 Diabetes (T2D) have a <span class="highlight">two- to four-fold increased risk</span> of cardiovascular events compared to those without diabetes. Even more concerning is the "diabetic heart" paradox: even when LDL cholesterol levels appear "normal" by conventional standards, the risk of myocardial infarction remains significantly elevated.</p>

        <p>This suggests that the traditional focus on total cholesterol or LDL-C is insufficient for the diabetic population. The pathology is driven not just by the quantity of lipids, but by the <span class="highlight">structural modification of those lipids</span> and the health of the vessel wall itself. As a Diabetes & Blood Sugar Coach, understanding these nuances is critical for moving beyond basic carb-counting into genuine life-saving advocacy.</p>

        <!-- Statistics Box -->
        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">65%</div>
                    <div class="stat-label">Diabetes Deaths from CVD</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">2-4x</div>
                    <div class="stat-label">Increased Stroke Risk</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">15yr</div>
                    <div class="stat-label">Earlier CVD Onset</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">16%</div>
                    <div class="stat-label">HF Risk per 1% A1c</div>
                </div>
            </div>
        </div>

        <h2 id="section2">Endothelial Dysfunction: The First Line of Defense</h2>

        <p>The endothelium is the single layer of cells lining our blood vessels. It is not a passive barrier; it is a dynamic endocrine organ that regulates blood flow, prevents clot formation, and controls inflammation. In the context of diabetes, the endothelium is the primary target of <span class="highlight">glucotoxicity</span>.</p>

        <p>High glucose levels impair the activity of <span class="highlight">Endothelial Nitric Oxide Synthase (eNOS)</span>, the enzyme responsible for producing Nitric Oxide (NO). NO is the bodyâ€™s natural vasodilator; it keeps vessels flexible and prevents platelets from sticking to the walls. When NO production drops due to oxidative stress (superoxide production), the vessels become stiff, narrow, and "sticky"â€”setting the stage for atherosclerosis.</p>

        <div class="key-terms-box">
            <p class="box-label">ðŸ”¬ Key Vascular Terms</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Glycocalyx</p>
                    <p class="definition">A delicate, gel-like layer on the endothelial surface that prevents cholesterol from entering the vessel wall. Hyperglycemia strips this layer within hours.</p>
                </div>
                <div class="term-item">
                    <p class="term">ApoB</p>
                    <p class="definition">A protein found on all atherogenic particles (LDL, VLDL, IDL). It is a more accurate predictor of CVD risk than LDL-C in diabetic patients.</p>
                </div>
                <div class="term-item">
                    <p class="term">Oxidative Stress</p>
                    <p class="definition">An imbalance between free radicals (ROS) and antioxidants, leading to damage of cellular proteins and DNA in the heart muscle.</p>
                </div>
            </div>
        </div>

        <h2 id="section3">The Atherogenic Triad: Beyond LDL</h2>

        <p>In diabetic patients, we frequently observe a specific pattern of dyslipidemia known as the <span class="highlight">Atherogenic Triad</span>. Even if the LDL-C (concentration) is target-range, the quality of the particles is highly pathological. This triad consists of:</p>

        <ol class="content-list">
            <li><strong>Hypertriglyceridemia:</strong> Elevated VLDL particles due to insulin resistance in the liver.</li>
            <li><strong>Low HDL-C:</strong> Reduced "protective" cholesterol, often combined with impaired HDL function.</li>
            <li><strong>Small Dense LDL (sdLDL):</strong> LDL particles that have been modified by high triglycerides and glucose.</li>
        </ol>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Marker</th>
                        <th>Standard Pattern</th>
                        <th>Diabetic/Insulin Resistant Pattern</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>LDL Particle Size</td>
                        <td>Pattern A (Large, Buoyant)</td>
                        <td>Pattern B (Small, Dense, Highly Atherogenic)</td>
                    </tr>
                    <tr>
                        <td>Triglycerides</td>
                        <td>&lt; 150 mg/dL</td>
                        <td>Often &gt; 200 mg/dL</td>
                    </tr>
                    <tr>
                        <td>HDL-C</td>
                        <td>&gt; 50 mg/dL</td>
                        <td>Often &lt; 40 mg/dL</td>
                    </tr>
                    <tr>
                        <td>TG/HDL Ratio</td>
                        <td>&lt; 2.0</td>
                        <td>&gt; 3.0 (Strong indicator of Insulin Resistance)</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>Small dense LDL particles are particularly dangerous because they are more likely to undergo <span class="highlight">glycation and oxidation</span>. Once glycated, they are no longer recognized by the standard LDL receptors in the liver, meaning they circulate longer and are more easily trapped in the sub-endothelial space, where they form plaque.</p>

        <h2 id="section4">Glycemic Variability (S) and Oxidative Damage</h2>

        <p>The "S" in the STABLE Methodâ„¢ stands for <span class="highlight">Stabilization of Glycemic Variability</span>. Research indicates that the "rollercoaster" of blood sugarâ€”sharp spikes followed by rapid dropsâ€”is more damaging to the cardiovascular system than a sustained, slightly elevated glucose level.</p>

        <p>A landmark study published in <i>Diabetes Care</i> demonstrated that fluctuating glucose levels trigger a greater degree of oxidative stress and endothelial apoptosis (cell death) than constant high glucose. Each "spike" generates a burst of superoxide radicals that neutralize Nitric Oxide. This is why a client with an A1c of 6.5% achieved through wild swings is at higher risk than a client with a 6.8% A1c and a flat glucose curve.</p>

        <!-- Case Study 1 -->
        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Normal LDL" Trap</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:13px;">Client: Robert, Age 56, T2D for 8 years</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>Presentation:</strong> Robertâ€™s physician was pleased with his "target" LDL-C of 92 mg/dL. However, Robertâ€™s Triglycerides were 210 mg/dL and HDL was 34 mg/dL. His CGM data showed post-meal spikes reaching 240 mg/dL daily (High Glycemic Variability).</p>
                <p><strong>Intervention:</strong> Using the <strong>STABLE Methodâ„¢</strong>, we focused on "Evolutionary Nutrition" (E) to flatten the curve (fiber-first food ordering) and "Active Sensitization" (A) via 10-minute post-meal walks to clear glucose without insulin spikes.</p>
                <p><strong>Outcome:</strong> After 12 weeks, Robertâ€™s TG dropped to 135 mg/dL, and his TG/HDL ratio improved from 6.1 to 3.2. A follow-up advanced lipid panel showed a shift from LDL Pattern B to Pattern A, significantly reducing his plaque-forming potential despite his LDL-C remaining stable.</p>
            </div>
        </div>

        <h2 id="section5">Advanced Biomarkers for the Diabetes Coach</h2>

        <p>To provide premium coaching, you must understand the markers that go beyond the basic panel. When reviewing lab work with clients (or encouraging them to request specific tests from their doctors), look for these "Red Flags":</p>

        <ul class="content-list">
            <li><strong>hs-CRP (High-Sensitivity C-Reactive Protein):</strong> A marker of systemic inflammation. Levels &gt; 2.0 mg/L indicate increased cardiovascular risk.</li>
            <li><strong>Apolipoprotein B (ApoB):</strong> Measures the total number of atherogenic particles. This is far superior to LDL-C for diabetic patients.</li>
            <li><strong>Lp(a) (Lp-little-a):</strong> A genetically determined, highly inflammatory cholesterol particle. Everyone should have this tested at least once.</li>
            <li><strong>HOMA-IR:</strong> Calculated from fasting insulin and glucose; directly measures the severity of insulin resistance driving the dyslipidemia.</li>
        </ul>

        <h2 id="section6">Implementing the STABLE Methodâ„¢ for Cardioprotection</h2>

        <p>The STABLE Methodâ„¢ provides a comprehensive framework for mitigating the CVD-Diabetes link through physiological synergy:</p>

        <div class="principle-card">
            <p class="principle-title">S: Stabilization & The Glycocalyx</p>
            <p class="principle-text">Reducing postprandial spikes to &lt; 140 mg/dL protects the endothelial glycocalyx. Even one hour of hyperglycemia (180+ mg/dL) can diminish glycocalyx volume by 50%, allowing cholesterol to infiltrate the vessel wall.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">A: Active Sensitization & Shear Stress</p>
            <p class="principle-text">Zone 2 aerobic exercise and resistance training improve "laminar shear stress." This physical movement of blood against the vessel wall stimulates eNOS to produce Nitric Oxide, naturally lowering blood pressure and improving vessel flexibility.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">L: Lifestyle & Circadian Rhythm</p>
            <p class="principle-text">Sleep apnea and poor sleep hygiene are independent risk factors for CVD in diabetes. One night of partial sleep deprivation increases morning cortisol and sympathetic tone, leading to vasoconstriction and higher blood pressure.</p>
        </div>

        <!-- Check Your Understanding -->
        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of the CVD-Diabetes link.</p>

            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Why is LDL-C (concentration) often a misleading marker in patients with Type 2 Diabetes?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Because T2D often produces "Small Dense LDL" (Pattern B). These particles are more atherogenic and prone to glycation, but because they are small, they don't carry much cholesterol volume, making the LDL-C measurement look deceptively "normal" or low.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">Which enzyme's impairment is primarily responsible for endothelial dysfunction in the presence of high glucose?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">eNOS (Endothelial Nitric Oxide Synthase). Hyperglycemia and oxidative stress uncouple this enzyme, leading to a decrease in Nitric Oxide (a vasodilator) and an increase in Superoxide (a harmful free radical).</div>
            </div>
        </div>

        <!-- Takeaways -->
        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>CVD is the leading cause of death in diabetes, driven by a combination of glucotoxicity and insulin resistance.</li>
                <li>The "Atherogenic Triad" (High TG, Low HDL, Small Dense LDL) is the hallmark of diabetic dyslipidemia.</li>
                <li>Glycemic variability is a more potent driver of vascular oxidative stress than sustained high blood sugar.</li>
                <li>Endothelial health depends on Nitric Oxide availability and the integrity of the glycocalyx layer.</li>
                <li>Coaches should look at the TG/HDL ratio and ApoB for a more accurate assessment of cardiovascular risk.</li>
            </ul>
        </div>

        <!-- References -->
        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Rawshani, A., et al. (2018). "Risk Factors, Adverse Outcomes, and Glycemic Control in Type 2 Diabetes." <i>New England Journal of Medicine</i>.</li>
                <li>Leon, B. M., & Ariyachaipanich, A. (2016). "Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, and therapies." <i>World Journal of Diabetes</i>.</li>
                <li>Monnier, L., et al. (2006). "Activation of Oxidative Stress by Glycemic Variability Compared With Sustained Hyperglycemia." <i>JAMA</i>.</li>
                <li>Bornfeldt, K. E., & Tabas, I. (2011). "Insulin Resistance, Hyperglycemia, and Atherosclerosis." <i>Cell Metabolism</i>.</li>
                <li>Ceriello, A., et al. (2019). "The role of glycemic variability in cardiovascular complication of diabetes." <i>Cardiovascular Diabetology</i>.</li>
                <li>Sniderman, A. D., et al. (2019). "Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review." <i>JAMA Cardiology</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">Diabetes & Blood Sugar Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>